What is the best sequential treatment strategy in the treatment of depression? adding pharmacotherapy to psychotherapy or vice versa?

Psychotherapy and Psychosomatics

Volumn 82, Issue 2, 2013, Pages 89-98

  Dekker, Jack ^a,d   Van, Henricus L ^a   Hendriksen, Mariëlle ^a   Koelen, Jurrijn ^b   Schoevers, Robert A ^c   Kool, S ^a   Van Aalst, G ^a   Peen, Jaap ^a  

^a Arkin Mental Health Institute   (Netherlands)

^b Altrecht Psychosomatic Medicine   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Depression; Pharmacotherapy; Psychodynamic psychotherapy; Sequential treatment strategy

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; NORTRIPTYLINE; VENLAFAXINE;

ADULT; ALGORITHM; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; DRUG DOSE TITRATION; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTPATIENT; PRIORITY JOURNAL; PSYCHODYNAMIC THERAPY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

ADULT; ALGORITHMS; AMBULATORY CARE; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT PREFERENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84871856652     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000341177     Document Type: Article

References (81)

1. Casacalenda N, Perry JC, Looper K: Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy and control conditions. Am J Psychiatry 2002; 159: 1354-1360.
2. Cuijpers P, van Straten A, Andersson G, van Oppen P: Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol 2008; 76: 909-922.
3. Cuijpers P, van Straten A, van Oppen P, Andersson G: Are psychological and pharmacological interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies. J Clin Psychiatry 2008; 69: 1675-1685.
4. Hollon SD, Jarrett RB, Nierenberg AA, Thase ME, Trivedi M, Rush AJ: Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychol 2005; 66: 455-468.
5. de Maat SM, Dekker J, Schoevers RA, de Jonghe F: Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis. Eur Psychiatry 2007; 22: 1-8.
6. Cuijpers P, Dekker J, Hollon SD, Andersson G: Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. J Clin Psychiatry 2009; 70: 1219-1229.
7. de Jonghe F, Kool S, van Aalst G, Dekker J, Peen J: Combining psychotherapy and antidepressants in the treatment of depression. J Affect Disord 2001; 64: 217-229.
8. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J: A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000; 342: 1462-1470.
9. de Jonghe F, Hendriksen M, van Aalst G, Kool S, Peen J: Psychotherapy alone and combined with pharmacotherapy in the treatment of depression. Br J Psychiatry 2004; 185: 37-45.
10. de Maat S, Dekker J, Schoevers R, de Jonghe F: Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis. Eur Psychiatry 2007; 22: 108.
11. de Maat S, Dekker J, Schoevers R, van Aalst G, Gijsbers-van Wijk C, Hendriksen M, Kool S, Peen J, Van R, de Jonghe F: Short psychodynamic supportive psychotherapy, antidepressants, and their combination in the treatment of major depression: a mega-analysis based on three randomized clinical trials. Depress Anxiety 2008; 25: 565-574.
12. Blom MBJ: Combination Treatment for Depressed Outpatients: Efficacy and Prediction of Outcome. Amsterdam, Free University of Amsterdam, 2008.
13. Segal Z, Vincent P, Levitt A: Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy improving outcomes in depression. J Psychiatry Neurosci 2002; 18: 1-19.
14. Fava M, Ruini C, Rafanelli C: Sequential treatment of mood and anxiety disorders. J Clin Psychiatry 2005; 66: 1392-1400.
15. Fava A, Tomba E: New modalities of assessment and treatment planning in depression. The sequential approach. CNS Drugs 2010; 24: 453-465.
16. Frank E, Grochocinski VJ, Spanier CA, Buysse DJ, Cherry CR, Houck PR: Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression. J Clin Psychiatry 2000; 61: 51-57.
17. Fava GA, Grandi S, Zielezny M, Canestrari R, Morphy MA: Cognitive behavioral treatment of residual symptoms in primary major depressive disorders. Am J Psychiatry 1994; 151: 1295-1299.
18. Fava GA, Grandi S, Zielezny M, Rafanelli C, Canestrari R: Four year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 1996; 153: 1443-1445.
19. Fava GA, Rafanelli C Grandi S, Canestrari R, Morphy MA: Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 1998; 155: 1443-1445.
20. Paykel ES, Scott J, Cornwal PL, Abbot R, Crane C, Pope M, Johnson AL: Duration of relapse prevention after cognitive therapy in residual depression: follow-up controlled trial. Br J Psychiatry 2005; 35: 59-68.
21. Teasdale JD, Segal ZV, Williams JMG, Ridgeway VA, Soulsby JM, Lou MA: Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000; 68: 615-623.
22. Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M: Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. J Clin Psychopharmacol 2002; 22: 474-480.
23. Petersen T, Harly R, Papakostas G, Montoya HD, Fava M, Alpert JE: Continuation cognitive behavioral therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine. Psychol Med 2004; 34: 555-561.
24. Ma SH, Teasdale JD: Mindfulness-based cognitive therapy. J Consult Clin Psychol 2004; 72: 31-40.
25. Bockting CLH, Schene AH, Spinhoven P, Koeter MW, Wouters LF, Huyser J, Kamphuis JH: Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial. J Consult Clin Psychol 2005; 73: 647-657.
26. Kuyken W, Byford S, Taylor RS, Watkins E, Hoden E, White K, Barrett B, Byng R, Evans A, Mullan E, Teasdale JD: Mindfulnessbased cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol 2008; 76: 966-978.
27. Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, Fava W, Nierenberg AA, McGrath PJ, Warden D, Niederehe G, Hollon SD, Rush AJ: Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR * D report. Am J Psychiatry 2007; 164: 739-752.
28. Leichsenring F, Rabung S, Leibing E: The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 2004; 61: 1208-1216.
29. Driessen E, Cuijpers P, de Maat SCM, Abbass A, de Jonghe F, Dekker JM: The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis. Clin Psychol Rev 2010; 30: 25-36.
30. Abbass A, Driessen, E: The efficacy of shortterm psychodynamic psychotherapy for depression: a summary of recent findings (letter to the editor). Acta Psychiatr Scand 2010; 121: 398-399.
31. Blagys M, Hilsenroth M: Distinctive features of short-term psychodynamic-interpersonal psychotherapy: an empirical review of the comparative psychotherapy process literature. Clin Psychol Sci Pract 2000; 7: 167-188.
32. Leichsenring F: Comparative effects of short-term psychodynamic psychotherapy and cognitive-behavioral therapy in depression: a meta-analytic approach. Clin Psychol Rev 2001; 21: 401-419.
33. Maina G, Rosso G, Crespi C, Bogetto F: Combined brief dynamic therapy and pharmacotherapy in the treatment of major depressive disorder: a pilot study. Psychother Psychosom 2007; 76: 298-305.
34. Maina G, Rosso G, Bogetto F: Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results. J Affect Disord 2009; 114: 200-207.
35. Salminen J, Karisson H, Hietala J, Kajander J, Aalto S, Markkula J, Rasi-Hakala H, Toikka T: Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom 2008; 77: 351-357.
36. Dekker JJM, Koelen JA, Van H, Schoevers RA, Peen J, Hendriksen M, Kool S, van Aalst G, de Jonghe F: Speed of action: the relative efficacy of short psychodynamic supportive psychotherapy and pharmacotherapy in the first 8 weeks of a treatment. J Affect Disord 2008; 109: 183-188.
37. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296.
38. Van HL, Dekker J, Koelen JA, Kool S, van Aalst G, Hendriksen M, Peen J, Schoevers RA: Patient preference compared with random allocation in short-term psychodynamic supportive psychotherapy with indicated addition of pharmacotherapy for depression. Psychother Res 2009; 19: 205-212.
39. Fava M, Davidson KG: Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996; 19: 179-200.
40. Fava M: Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003; 53: 649-659.
41. Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Pava JA, Rosenbaum JF: Major depressive subtypes and treatment response. Biol Psychiatry 1997; 42: 568-576.
42. Van Henricus L, Dekker J, Peen J, van Aalst G, Schoevers RA: Identifying patients at risk for complete nonresponse in the outpatients treatment of depression. Psychother Psychosom 2008; 77: 358-364.
43. Dekker J, Molenaar PJ, Kool S, van Aalst G, Peen J, de Jonghe F: Dose effect relations in time-limited combined psycho-pharmacological treatment for depression. Psychol Med 2005; 35: 47-58.
44. Hendriksen M, Van HL, Schoevers RA, de Jonghe F, Gijsbers-van Wijk CM, Peen J, Dekker JJ: Therapist judgment of defense styles and therapeutic technique related to outcome in psychodynamic psychotherapy of depression. Psychother Psychosom 2011; 80: 377-379.
45. Kool S, Dekker J, Duijsens IJ, de Jonghe F, Puite B: Changes in personality pathology after pharmacotherapy and combined therapy for depressed patients. J Pers Disord 2003; 17: 60-72.
46. Kool S, Dekker J, Duijsens IJ, de Jonghe F, Puite B: Efficacy of combined therapy and pharmacotherapy with depressed patients with or without personality disorders. Harv Rev Psychiatry 2003; 11: 133-141.
47. Dekker J, Koelen JA, Van HL, Schoevers RA, Peen J, Hendriksen, M, Kool S, van Aalst G, de Jonghe F: Speed of action: the relative efficacy of short psychodynamic supportive psychotherapy and pharmacotherapy in the first 8 weeks of a treatment algorithm for depression. J Affect Disord 2008; 109: 183-188.
48. de Jonghe F, Hendriksen M, van Aalst G, Kool S, Peen J, Van R, van den Eijnden E, Dekker J: Psychotherapy alone and combined with pharmacotherapy in the treatment of depression. Br J Psychiatry 2004; 185: 37-45.
49. de Maat S, Dekker J, Schoevers R, van Aalst G, de Jonghe F, Gijsbers-van Wijk C, Hendriksen M, Kool S, Peen J, Van R: Short psychodynamic supportive psychotherapy, antidepressants, and their combination in the treatment of major depression: a mega-analysis based on three randomized clinical trials. Depress Anxiety 2008; 25: 565-574.
50. Molenaar, P, Dekker J, Schouws S, Peen J, Schoevers R: Recovery of social functioning during the treatment of depression. Depress Anxiety 2006; 23: 1-10.
51. Van HL, Schoevers RA, Kool S, Hendriksen M, Peen J, Dekker J: Does early response predict outcome in psychotherapy and combined therapy for major depression? J Affect Disord 2008; 105: 261-265.
52. Van HL, Dekker J, Koelen J, Kool S, van Aalst G, Hendriksen M, Peen J, Schoevers R: Patient preference compared with random allocation in short-term psychodynamic supportive psychotherapy with indicated addition of pharmacotherapy for depression. Psychother Res 2009; 19: 205-212.
53. de Jonghe F, Rijnierse P, Janssen R: Psychoanalytic supportive psychotherapy. J Am Med Assoc 1994; 42: 421-446.
54. de Jonghe F: Kort en Krachtig (Brief and Potent). Short Psychodynamic Supportive Psychotherapy. Amsterdam, Benecke, 2005.
55. de Jonghe F, Dekker J, Kwakman H, Huyser J: Sensitivity of the depression and anxiety list (DAL) to early response in patients with major depression treated with antidepressants. Int J Methods Psychiatr Res 1996; 5: 1-5.
56. Huyser J, de Jonghe F, Jonkers F, Schalken HFA: The Manual for the Diagnosis of Major Depression (MDMD): description and reliability. Int J Methods Psychiatr Res 1996; 6: 1-4.
57. Guy W: ECDEU Assessment Manual for Psychopharmacology (revised). US Department of Health, Education and Welfare Pub. Rockville, National Institute of Mental Health, DHEW Publ No ADM 76-338, 1976.
58. Arrindell WA, Ettema JMM: SCL-90. Handleiding bij een multidimensionele psychopathologie-indicator. Lisse, Swets and Zeitlinger, 1986.
59. Tuynman-Qua H, de Jonghe F: Quality of Life Depressie Schaal. Houten, Ibero, 1992.
60. Wisniewski SR, Fava M, Trivedi MH, Thase ME, Warden D, Niederehe G, Friedman ES, Biggs MM, Sackeim HA, Shores-Wilson K, McGrath PJ, Lavori PW, Miyahar AS, Rush AJ: Acceptability of second-step treatment of depressed outpatients: a STAR * D report. Am J Psychiatry 2007; 164: 753-760.
61. Pigott HE, Leventhal AM, Alter GS, Boren JJ: Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom 2010; 79: 267-279.
62. Hoyer J, Höfler M: Do pharmacotherapy and/or psychotherapy work in depression? It depends! Psychother Psychosom 2011; 80: 245.
63. Huf W, Kalcher K, Kasper S: Widespread methodological problems limit validity of meta-analytic results. Psychother Psychosom 2011; 80: 246.
64. Pigott HE, Alter GS: In response to 'Do pharmacotherapy and/or psychotherapy work in depression? It depends!' and 'Widespread methodological problems limit validity of meta-analytic results'. Psychother Psychosom 2011; 80: 247-248.
65. Linham R, Scott J: Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002; 105: 164-172.
66. Demyttenaere K: Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol 2003; 13(suppl 3):S69-S75.
67. Simons AD, Levine JL, Lustman PJ, Murphy GE: Patient attrition in a comparative outcome study of depression: a follow-up report. J Affect Disord 1984; 6: 163-173.
68. Reynolds CF, Frank E, Perel JM, Imber SD, Cornes C, Morycz RK, Mazumdar S, Miller MD, Pollock BG, Rifai AH: Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report. Am J Psychiatry 1992; 49: 1687-1692.
69. Christensen H, Griffiths KM, Mackinnon AJ, Brittliffe K: Online randomized controlled trial of brief and full cognitive behaviour therapy for depression. Psychol Med 2006; 36: 1737-1746.
70. Cahill J, Barkham M, Hardy G, Rees A, Shapiro DA, Stiles WB, Macaskill N: Outcomes of patients completing and not completing cognitive therapy for depression. Br J Clin Psychol 2003; 42: 133-143.
71. Blom MB, Spinhoven P, Hoffman T, Jonker K, Hoencamp E, Haffmans PM, van Dyck R: Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. J Affect Disord 2007; 104: 119-126.
72. Warden D, Trevedi MH, Wisniewski R, Lesser IM, Mitchell J, Balasubramani GK, Fava M, Shores-Wilson K, Stegman D, Rush AJ: Identifying risk for attrition during treatment for depression. Psychother Psychosom 2009; 78: 372-379.
73. Cheng M: New approaches for creating the therapeutic alliance: solution-focused interviewing, motivational interviewing, and the medication interest model. Psychiatr Clin North Am 2007; 30: 157-166.
74. Ruhé HG, Dekker JJ, Peen J, Holman R, de Jonghe F: Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores. Compr Psychiatry 2005; 46: 417-427.
75. Mergl R, Henkel V, Allgaier A, Kramer D, Hautzinger M, Kohnen R, Coyne J, Heger U: Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients' choice arm. Psychother Psychosom 2011; 80: 39-47.
76. Lacoviello BM, Alloy LB, Abramson LY, Whitehouse WG, Hogan ME: The role of cluster B and C personality disturbance in the course of depression: a prospective study. J Pers Disord 2007; 21: 371-383.
77. Lichtenberg P, Belmaker R: Subtyping major depressive disorder. Psychother Psychosom 2010; 79: 131-135.
78. Smits JAJ, Minhajuddin A, Thase ME, Jarrett RB: Outcomes of acute phase cognitive therapy in outpatients with anxious versus nonanxious depression. Psychother Psychosom 2012; 81: 153-160.
79. Tomba E: Nowhere patients. Psychother Psychosom 2012; 81: 69-72.
80. Bech P: Struggle for subtypes in primary and secondary depression and their mode-specific treatment or healing. Psychother Psychosom 2010; 79: 331-338.
81. Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina, Flynn M, Harper L, Levy M, Rickels K, Pollack M: A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A study). Psychother Psychosom 2012; 81: 87-97.